Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Publication year range
1.
Clin Exp Dermatol ; 34(5): e78-80, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19438546

ABSTRACT

We report three cases of neonatal haemangiomatosis associated with large placental chorioangioma. Pregnancies were complicated by polyhydramnios, and all mothers underwent amniocentesis to drain the liquid. Steroid treatment was required for two children. Although the theory has been largely disproved in normal haemangiomas, embolization of precursor endothelial cells derived from placental vessels is a likely explanation for the pathogenesis of haemangiomatosis associated with large placental chorioangiomas.


Subject(s)
Hemangioma/pathology , Placenta Diseases/pathology , Skin Neoplasms/pathology , Female , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/pathology , Pregnancy
2.
Hautarzt ; 52(11): 1026-9, 2001 Nov.
Article in German | MEDLINE | ID: mdl-11757457

ABSTRACT

A 12 year old boy developed scars at light-exposed areas following long-term therapy with naproxen for rheumatoid arthritis. Erythrocyte and urine porphyrin levels were not increased, and there was no evidence of increased photosensitivity. Pseudoporphyria is reported in 10-20% of those treated with naproxen for > 4 weeks. As compared to other nonsteroidal anti-inflammatory agents, the specific risk for naproxen is increased about 6fold. While the underlying abnormality has not been elucidated, formation of phototoxic metabolites in a subgroup of genetically predisposed individuals has been suggested as the most likely mechanism. Both dermatologists and rheumatologists should be aware of the risk of naproxen-induced pseudoporphyria and discontinue therapy early in order to avoid scar formation in light-exposed areas.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Naproxen/adverse effects , Porphyrias/chemically induced , Arthritis, Rheumatoid/drug therapy , Child , Humans , Male , Naproxen/administration & dosage , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...